could not be determined without molecular analysis. This abnormality is considered a masked type of translocation 8;21.
INTRODUCTION
The translocation (8;21)(q22;q22) is frequently associated with the M2 subtype of acute myelogenous leukemia (AML) designated according to the French-American-British (FAB) classification [1, 2] . As large scale studies suggested that patients with AML carrying t (8;21) have a good prognosis, it is thought to be important for clinicians to differentiate this translocation from other chromosomal abnormalities. This translocation involves the AML1 gene on chromosome 21 and the ETO gene on chromosome 8, leading to formation of a chimeric AML1/ETO fusion gene on the derived chromosome 8. However, the AML1/ETO fusion transcripts without cytogenetic evidence of the classical t(8;21)(q22;q22) was identified in some cases, which was designated as a masked type of t(8;21). Some patterns of complex chromosomal translocation were reported related to masked t(8;21). We describe a case of a masked t(8;21) in which insertion of 8q22 into 21q22 resulted in formation of the AML1/ETO fusion gene on chromosome 21.
CASE REPORT
In May 2001, a 43-year-old man visited a hospital because of malaise and left sided headache.
Because of leukocytosis, thrombocytopenia and anemia, he was transferred to our hospital on June 7. Physical examination on admission showed purpura in the right lower extremity.
Peripheral blood counts were: hemoglobin 6.5g/dl, platelets 0.6x10 4 The patient was diagnosed as having the M2 subtype of AML according to the FAB classification. Induction chemotherapy with daunomycin, citarabine, 6-melcaptopurine and predonisolone was performed to achieve complete remission (CR). However, he relapsed after four courses of consolidating chemotherapy. Re-induction chemotherapy with high dose cytarabine was performed and achieved the second CR.
MATERIALS AND METHODS

Cytogenetics
We used standard cytogenetic techniques to determine the karyotype. Bone marrow cells were cultured for 24 hours in RPMI1640 (SIGMA, MO, USA) supplemented with 10% bovine serum (GIBCO BRL, NY, USA), and antibiotics. Chromosomal analysis was carried out on G-banded preparations.
RNA isolation and Reverse transcription-polymerase chain reaction (RT-PCR)
RNA isolation and RT-PCR were carried out according to a method designed and confirmed by the BML Laboratory (Tokyo, Japan). RNA was extracted from the patient's bone marrow samples using Trizol (GIBCO BRL, NY, USA) and precipitated with isopropyl alcohol. applied: at 94℃ for 2 minutes for denaturing, at 60℃ for 1 minute for annealing and 72℃ for 1 minute and 30 seconds for extension of the product. PCR products were electrophoresed in a 3% agarose gel containing ethidium bromide and visualized on a UV transilluminator. The cDNA derived from the patient's sample and a control was simultaneously subjected to PCR for assessment. The ETO gene was amplified using an optimal set of primers as an internal control.
Fluorescence in situ hybridization (FISH)
Double color FISH was perfomed using probes for AML1 and the ETO gene (LSI AML1/ETO dual color dual fusion translocation probe, Vysis, IL, USA). Whole chromosome painting probes of chromosomes 8 and 21 (Vysis) were used for whole chromosome painting FISH.
RESULTS
Cytogenetics
The -5 -
RT-PCR Analysis
RT-PCR showed a positive amplification for the AML1/ETO fusion transcript (Figure2).
FISH Analysis
Results of dual-color FISH with AML1 and ETO probes are shown in Figure 3 [5, 16] . Only molecular analysis revealed the presence of AML1/ETO fusion gene in these cases that could be thought to have otherwise normal karyotype.
Submicroscopic translocations can also be detected by FISH analysis combined with other molecular studies. In 6 reports of masked t(8;21), the precise translocations were determined by FISH analysis [9, 11, 13, 14, 15, 16] . 
